Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation.

by Sylvie Perreault, Robert Côté, Alice Dragomir, Brian White-Guay, Aurélie Lenglet, Marc Dorais
Published 2022-01-01

Effectiveness and safety of low-dose versus standard-dose rivaroxaban and apixaban in patients with atrial fibrillation

by Sylvie Perreault, Robert Côté, Alice Dragomir, Brian White-Guay, Aurélie Lenglet, Marc Dorais
Published 2022-01-01

Acceptance Factors for In-Hospital Pharmacist Interventions in Daily Practice: A Retrospective Study

by Amaury Durand, Amaury Durand, André Gillibert, Sophie Membre, Lisa Mondet, Aurélie Lenglet, Aurélien Mary
Published 2022-03-01

Trends of use and factors that determine the choice of oral anticoagulants in women and men with atrial fibrillation

by Aurélie Lenglet, Jakub Z. Qazi, Laurie‐Anne Boivin Proulx, Catherine Legault, Marc Dorais, Sylvie Perreault
Published 2022-12-01

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation

by Sylvie Perreault, Alice Dragomir, Robert Côté, Aurélie Lenglet, Aurélie Lenglet, Simon de Denus, Simon de Denus, Marc Dorais, Brian White-Guay, James Brophy, Mireille E. Schnitzer, Marie-Pierre Dubé, Marie-Pierre Dubé, Jean-Claude Tardif, Jean-Claude Tardif
Published 2022-01-01

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease

by European Uremic Toxin (EUTox) Work Group, Ziad A. Massy, Horst-Dieter Lemke, Raymond Vanholder, Gabriel Choukroun, Aurélie Lenglet, Lucie Desjardins, Sophie Liabeuf
Published 2013-11-01

Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease.

by Nathalie Neirynck, Sunny Eloot, Griet Glorieux, Daniela V Barreto, Fellype C Barreto, Sophie Liabeuf, Aurélie Lenglet, Horst D Lemke, Ziad A Massy, Raymond Vanholder
Published 2012-01-01

Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?

by Sophie Liabeuf, Griet Glorieux, Aurelie Lenglet, Momar Diouf, Eva Schepers, Lucie Desjardins, Gabriel Choukroun, Raymond Vanholder, Ziad A Massy, European Uremic Toxin (EUTox) Work Group
Published 2013-01-01

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

by Aurélie Lenglet, Sophie Liabeuf, Sandra Bodeau, Loïc Louvet, Aurélien Mary, Agnès Boullier, Anne Sophie Lemaire-Hurtel, Alexia Jonet, Pascal Sonnet, Said Kamel, Ziad A. Massy
Published 2016-11-01